The European Medicines Agency has published a new list of “critical medicines” intended to help companies and national regulators map the drugs in its Product Management Service (PMS).
Manufacturing authorization holders (MAHs) can prioritize the medicines in the list for the submission of specific product information relating to pack sizes and manufacturing, while national competent authorities (NCAs) can...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?